HOME >> BIOLOGY >> NEWS
16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

The 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics brings 2,000 international cancer experts together to present new data on leading-edge basic, translational and early clinical research.

News briefing:

12.30 hrs CET Wednesday 29 September:

Speakers and topics

    * Dr Monika Hegi: Trial identifies which brain cancer patients benefit from temozolomide: genetic predictive test can be carried out in any laboratory and means temozolomide can now become a targeted treatment.

    * Dr Ardeshir Ghavamzadeh: Trial results indicate arsenic should now be considered first-line treatment for one type of leukaemia

    *Dr Kim Chi: Successful results of Phase I trial of the first second generation antisense cancer drug - phase II getting under way

    * Dr Grant McArthur: Award winning researcher reveals potential new role for Glivec in a soft tissue cancer

Chairman: Professor Jaap Verweij (EORTC chairman of conference scientific committee) together with scientific committee co-chairmen Dr Janet Dancey (NCI) and Dr Eric K Rowinsky (AACR)

NB: any reports involving the topics outlined above are embargoed until the time and date of the news briefings.

Journalists wishing to dial in to the news briefing should contact Margaret Willson by Friday 25 September.

More information:

Margaret Willson
Conference Press Officer

Tel: 44-153-677-2181 (office)
44-797-385-3347 (mobile)
Email: m.willson@mwcommunications.org.uk

Conference media centre:
From 16.00 hrs CET Monday 27 September to 17.00 hrs CET Friday 1 October
Tel: 41-22-761-2205
Fax: 41-22-761-2211


'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-015-367-72181
European Organisation for Research and Treatment of Cancer
22-Sep-2004


Page: 1

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. Health of worlds sea lions the focus of Wakefield Symposium
4. Chemical signals health of brain cells Symposium
5. Final Alert: 16th EORTC NCI AACR Symposium
6. 16th EORTC NCI AACR Symposium
7. Symposium to tackle questions of genetic engineering and biodiversity
8. Fostering Diversity in the Sciences Symposium
9. Annual Chemical Biology Symposium at Yale May 14, 2004
10. Symposium relates long-term ecological research to ecosystem management
11. Symposium examines the growing influence of aerosols on climate

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... 12, 2017 , ... The Blavatnik Family Foundation and the ... of the 2017 Blavatnik Regional Awards for Young Scientists. Established in 2007, ... the New York Academy of Sciences to honor the excellence of outstanding postdoctoral ...
(Date:10/12/2017)... ... , ... AMRI, a global contract research, development and manufacturing ... and quality of life, will now be offering its impurity solutions as a ... requirements for all new drug products, including the finalization of ICH M7 earlier ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
Breaking Biology Technology:
Cached News: